These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4896867)

  • 1. [Adrenergic amines and monoaminoxidases in essential arterial hypertension].
    Sicuteri F; Buffoni F; Michelacci S; Del Bene E
    Acta Vitaminol Enzymol; 1969; 23(1):45-63. PubMed ID: 4896867
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinico-pharmacological model of paroxysmal arterial hypertension].
    Sicuteri F; Del Bene E; Tarquini B; Fanciullacci M
    Rass Neurol Veg; 1968; 22(1):63-82. PubMed ID: 5718883
    [No Abstract]   [Full Text] [Related]  

  • 3. [Monoamine oxidase and essential arterial hypertension].
    Sicuteri F; Del Bene E; Anselmi B; Del Bianco PL
    Boll Soc Ital Biol Sper; 1967 Sep; 43(17):1055-8. PubMed ID: 6077438
    [No Abstract]   [Full Text] [Related]  

  • 4. Migraine-headache and essential arterial hypertension. A clinical pharmacological approach with the false transmitter metaraminol.
    Sicuteri F; Del Bianco PL; Del Bene E
    Res Clin Stud Headache; 1970; 3():284-98. PubMed ID: 5527209
    [No Abstract]   [Full Text] [Related]  

  • 5. [Disorder of monoamine oxidase activity in essential arterial hypertension].
    Sicuteri F; Buffoni F; Michelacci S; Fanciullacci M
    Boll Soc Ital Cardiol; 1968; 13(6):944-7. PubMed ID: 5745659
    [No Abstract]   [Full Text] [Related]  

  • 6. [Role of central catecholamines in blood pressure regulation of spontaneously hypertensive rat].
    Yamori Y
    Saishin Igaku; 1971 Nov; 26(11):2063-73. PubMed ID: 4946774
    [No Abstract]   [Full Text] [Related]  

  • 7. Monoamine oxidase inhibitors--current status.
    Zemishlany Z; Radwan M; Wijsenbeek H
    Isr J Psychiatry Relat Sci; 1983; 20(3):254-71. PubMed ID: 6325369
    [No Abstract]   [Full Text] [Related]  

  • 8. Monoamine oxidase in health and disease.
    Udupa A; Srinivasan S; Udupa KN
    Indian J Physiol Pharmacol; 1974; 18(2):73-85. PubMed ID: 4414711
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on mode of action of monoamine oxidase inhibitors on the experimental hypertension of the rat].
    Nagata C
    Nihon Naika Gakkai Zasshi; 1970 Apr; 59(4):319-28. PubMed ID: 5462887
    [No Abstract]   [Full Text] [Related]  

  • 10. In vivo inhibition of dopamine beta-hydroxylase by 1-phenyl-3-(2-thiazolyl)-2-thiourea (U-14,624).
    Johnson GA; Boukma SJ; Kim EG
    J Pharmacol Exp Ther; 1970 Jan; 171(1):80-7. PubMed ID: 5410940
    [No Abstract]   [Full Text] [Related]  

  • 11. The mechanism of norepinephrine depletion by reserpine, metaraminol and related agents. The role of monoamine oxidase.
    Shore PA
    Pharmacol Rev; 1966 Mar; 18(1):561-8. PubMed ID: 4379288
    [No Abstract]   [Full Text] [Related]  

  • 12. The multiple monoamine oxidases.
    Wyatt RJ
    Adv Biochem Psychopharmacol; 1974; 12(0):1-2. PubMed ID: 4529309
    [No Abstract]   [Full Text] [Related]  

  • 13. New contributions from basic science to understanding the effects of monoamine oxidase inhibiting antidepressants.
    Murphy DL; Garrick NA; Aulakh CS; Cohen RM
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):37-43. PubMed ID: 6735994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of methyldopa and related agents on pressor responses to tyramine in reserpine-pretreated rats and dogs.
    Torchiana ML; Wenger HC; Stavorski J; Ludden CT; Stone CA
    J Pharmacol Exp Ther; 1966 Feb; 151(2):242-52. PubMed ID: 5932601
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anti-monoamine-oxidase activity of some beta-acyl-phenylhydrazines].
    Arrigo Reina R; Mazzone G
    Boll Soc Ital Biol Sper; 1970 Dec; 46(24):1041-4. PubMed ID: 5519865
    [No Abstract]   [Full Text] [Related]  

  • 16. Debrisoquin, a selective inhibitor of intraneuronal monoamine oxidase in man.
    Pettinger WA; Korn A; Spiegel H; Solomon HM; Pocelinko R; Abrams WB
    Clin Pharmacol Ther; 1969; 10(5):667-74. PubMed ID: 5808462
    [No Abstract]   [Full Text] [Related]  

  • 17. [Role of the adrenergic sympathetic system and diagnostic and therapeutic reflections].
    Valori C; Biancifiori M; Pinchi G; Agabiti-Rosei E
    Atti Soc Ital Cardiol; 1978; 37():29-45. PubMed ID: 687231
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the mechanism of the effect of higher fatty acids on mitochondrial monoamine oxidase activity].
    Rapava EA; Kliashtorin LB; Gorkin VZ
    Biokhimiia; 1966; 31(6):1216-24. PubMed ID: 5999850
    [No Abstract]   [Full Text] [Related]  

  • 19. [Monoamine oxidase inhibition and hypertensive paroxysms: importance of the method of administration].
    Sicuteri F; Del Bianco PL; Del Bene E
    Boll Soc Ital Biol Sper; 1966 Sep; 42(17):1163-6. PubMed ID: 5971368
    [No Abstract]   [Full Text] [Related]  

  • 20. [Inadequacy of the monoamine oxidase system--the probable pathogenetic factor in schizophrenia (review)].
    Kolpakov VG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(8):1254-63. PubMed ID: 4278558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.